|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2000-6-21
|
|
pubmed:abstractText |
We compared the effects of atenolol (50 mg), amlodipine (5 mg), enalapril (20 mg), hydrochlorothiazide (25 mg), and losartan (50 mg) given in once-daily oral doses on office and ambulatory blood pressures (BPs) in patients with hypertension and obstructive sleep apnea (OSA). Each of 40 randomized patients was treated in sequence with two of the five agents (balanced incomplete block design). Treatment periods lasted 6 wk and were separated by a 3-wk washout period. Changes in BP from baseline with the study substances were compared through analysis of variance. Office diastolic BP, our primary outcome variable, was most effectively lowered by atenolol, with all four post hoc differences between atenolol and the remaining substances being statistically significant. Reductions in office systolic and daytime ambulatory BP were not significantly different among the five compounds. However, atenolol reduced mean nighttime ambulatory diastolic and systolic BP more effectively than did amlodipine, enalapril, or losartan (but not hydrochlorothiazide). Severity of sleep-disordered breathing and well-being during the day were not significantly influenced by any of the study compounds. Our findings are in accordance with the hypothesis that an overactivity of the sympathetic nervous system is an important mechanism behind the development or maintenance of hypertension in patients with OSA.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1073-449X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
161
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1423-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10806134-Adrenergic beta-Antagonists,
pubmed-meshheading:10806134-Adult,
pubmed-meshheading:10806134-Aged,
pubmed-meshheading:10806134-Amlodipine,
pubmed-meshheading:10806134-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:10806134-Antihypertensive Agents,
pubmed-meshheading:10806134-Atenolol,
pubmed-meshheading:10806134-Blood Pressure Monitoring, Ambulatory,
pubmed-meshheading:10806134-Calcium Channel Blockers,
pubmed-meshheading:10806134-Cross-Over Studies,
pubmed-meshheading:10806134-Diuretics,
pubmed-meshheading:10806134-Double-Blind Method,
pubmed-meshheading:10806134-Humans,
pubmed-meshheading:10806134-Hydrochlorothiazide,
pubmed-meshheading:10806134-Hypertension,
pubmed-meshheading:10806134-Losartan,
pubmed-meshheading:10806134-Male,
pubmed-meshheading:10806134-Middle Aged,
pubmed-meshheading:10806134-Single-Blind Method,
pubmed-meshheading:10806134-Sleep Apnea, Obstructive,
pubmed-meshheading:10806134-Sodium Chloride Symporter Inhibitors
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea.
|
|
pubmed:affiliation |
Department of Pulmonary Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
